Evidence map›Paper›PMID 34832508›Full record

ReviewPathogens (Basel, Switzerland)2021

Recent Progress in

Itziar Chapartegui-González, Sarah Bowser, Alfredo G Torres, Nittaya Khakhum

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Biosafety and biosecurity forClinical microbiology reviews · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Design of a Bacteriophage Cocktail Active againstAntibiotics (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Itziar Chapartegui-GonzálezDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA.ORCID 0000-0001-7878-4499
Sarah BowserDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA.
Alfredo G TorresDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA.ORCID 0000-0001-6450-0643
Nittaya KhakhumDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77550, USA.
The University of Texas Medical Branch at Galveston · US

Funding

Glycoconjugate Nanoparticle Vaccines Against Burkholderia InfectionsR01AI126601 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI TORRES, ALFREDO G · 2016 to 2020
$2.1M
NIAID NIH HHS R01 AI126601NIH HHS AI126601NIH HHS AI148913
6 · The paper itself

Abstract

Significant advancement has been made in the development of vaccines against bacterial pathogens. However, several roadblocks have been found during the evaluation of vaccines against intracellular bacterial pathogens. Therefore, new lessons could be learned from different vaccines developed against unrelated intracellular pathogens. Bacillary dysentery and melioidosis are important causes of morbidity and mortality in developing nations, which are caused by the intracellular bacteria

Indexed as

Burkholderia pseudomalleiglycoconjugate vaccineslive attenuatedShigellasubunit vaccinesvaccines

Identifiers

PMID34832508
PMCPMC8621228
OpenAlexW3206903322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.